Mikael Dolsten

Chief Scientific Officer and President, Worldwide Research, Development and Medical

Pfizer

Social profiles

Get Free Access to Mikael’s Contact Info

Connect with Mikael Dolsten, Now

Reveal the information hidden below for free

Phone (Direct)

+1 212 ❅❅❅ ❅❅❅❅

Phone (Direct)

Phone (HQ)

(212) 733-2323

Phone (HQ)

❅❅❅❅❅@pfizer.com

❅❅❅❅❅@gmail.com

Office Address (HQ)

235 E 42nd Street, New York City, New York, 10017, United States

Office Address (HQ)

Reveal for Free

Work Biography for Mikael Dolsten, Pfizer

Mikael Dolsten works as a Chief Scientific Officer and President, Worldwide Research, Development and Medical at Pfizer, which is a Manufacturing company with an estimated 79 K employees; and founded in 1849. They are part of the Medical Research team within the Medical & Health Department and their management level is C-Level. Mikael graduated from Cambridge and is currently based in New York City, United States. They used to work at The New York Academy of Sciences and Muslim Science and have used the following emails: @pfizer.com, @orbimed.com, @red.boehringer-ingelheim.com.

Follow Mikael Dolsten on LinkedIn to get to know them better.

Flattery will get you everywhere, offer Mikael a compliment to ❄️

Previous Work Experience

2003 - 2021

Worldwide RD Advert

Chief Scientific Officer and President

2017 - 2020

The New York Academy of Sciences

Governor

2011 - 2011

Muslim Science

International Member

BI WORLDWIDE

Member of the Corporate Management Team

Education

Ph. D.

University of Lund

M. D.

Cambridge

Mikael's Workplace

Pfizer

Founded in 1849, Pfizer is headquartered in New York City, New York. They are a pharmaceutical manufacturing company with a focus on internal medicine, inflammation, rare disease, vaccines, and more.

235 E 42nd Street, New York City, New York, 10017, United States

79 K

$69.3 B

Manufacturing, Pharmaceuticals

Get Full Profile Access

Ice Breakers

Warm up a cold prospect with Datanyze ice breakers

Mikael’s company in the news

SHAREHOLDER ALERT: Weiss Law Reminds BHVN, SWCH, Y, and PLAN Shareholders About Its Ongoing Investigations

May 26, 2022

The Petri Dish: NIH gives $68M to Pfizer-partnered AI startup

May 26, 2022

Bill Gates and Pfizer's CEO Don't Want the World to Ignore Covid-19 - Barron's

May 26, 2022

Insights to Break the Ice

In your first interaction

Mikael’s CEO is Albert Bourla

Mikael is located in United States

Mikael has been Chief Scientific Officer and President, Worldwide Research, Development and Medical in Pfizer for 21 years

Pfizer’s Funding

Last funding

$1B

March 30, 2020

Total raised

$1B

Recommended Leads

Based on Mikael Dolsten's profile and your recent activity, these leads picked for you

Name & Title	Contact Info
Albert Bourla Chairman & Chief Executive Officer	❅❅❅❅❅@pfizer.com	Visit Profile
Dione Kobayashi Principal Scientist		Visit Profile
Andy Schmeltz Global President, Oncology	❅❅❅❅❅@pfizer.com +1 212 ❅❅❅ ❅❅❅❅	Visit Profile
Bill Carapezzi Executive VP, Global Business Services & Transformation	❅❅❅❅❅@pfizer.com +1 908 ❅❅❅ ❅❅❅❅	Visit Profile
Omar Gomez Chief Financial Officer & Finance Director (Mexico and Central America)	❅❅❅❅❅@pfizer.com +506 7❅❅❅ ❅❅❅❅	Visit Profile
Wu Xiaobing China Regional President		Visit Profile
Doug Lankler Executive VP & General Counsel	❅❅❅❅❅@pfizer.com +1 212 ❅❅❅ ❅❅❅❅	Visit Profile
Najah Sampson President (Canada)	❅❅❅❅❅@pfizer.com +1 212 ❅❅❅ ❅❅❅❅	Visit Profile